Cannon G B, Dean J H, Herberman R B, Perlin E, Reid J, Miller C, Lang N P
Int J Cancer. 1980 Jan 15;25(1):9-17. doi: 10.1002/ijc.2910250103.
Thirty-five patients with Stage I carcinoma of the lung were tested postoperatively to assess lymphoproliferative responses. Depressed lymphocyte proliferation (LP) responses to alloantaigen in the mixed leukocyte culture (MLC) as measured by thee relative proliferation index (RPI) were associated with a significantly shorter disease-free interval. In this group of patients, the immunologic responses predicted subsequent clinical course better than the TNM classification or the histological type of the tumor, and therefore this procedure appears promising for improved staging of patients with early stages of lung cancer (stage I lung cancer and T1N0M0). The depressed response to alloantaigen was a more sensitive discriminator of disease recurrence than PHA alone or even conbined with PHA.
对35例I期肺癌患者进行术后检测,以评估其淋巴细胞增殖反应。通过相对增殖指数(RPI)测量,混合淋巴细胞培养(MLC)中对同种异体抗原的淋巴细胞增殖(LP)反应降低与无病生存期显著缩短相关。在这组患者中,免疫反应比肿瘤的TNM分类或组织学类型更能预测后续临床病程,因此该方法对于改善早期肺癌(I期肺癌和T1N0M0)患者的分期似乎很有前景。对同种异体抗原的反应降低比单独使用PHA甚至与PHA联合使用更能敏感地鉴别疾病复发。